Overview
Lorenzo Lavarini-Jonghi practices practicing medicine in Cremona, Italy.
His clinical expertise encompasses Primary Mediastinal B-Cell Lymphoma (PMBCL).
He is actively involved in clinical research, co-authoring 10 peer reviewed articles.
Gender
Locations
Cremona, 26100, Italy
Monza, 20900, Italy
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Lorenzo Lavarini-Jonghi
Is Lorenzo Lavarini-Jonghi a top-rated expert for Primary Mediastinal B-Cell Lymphoma (PMBCL)?
MediFind is an objective health platform that identifies experts based on real-world data. Lorenzo Lavarini-Jonghi is classified as an Experienced expert for Primary Mediastinal B-Cell Lymphoma (PMBCL), meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Lorenzo Lavarini-Jonghi participate in research or clinical trials?
Yes. Lorenzo Lavarini-Jonghi has published 10 articles and abstracts on conditions like Primary Mediastinal B-Cell Lymphoma (PMBCL). You can view a list of Lorenzo Lavarini-Jonghi's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- Primary Mediastinal B-Cell Lymphoma (PMBCL)Mr. Lavarini-Jonghi isExperienced. Learn about Primary Mediastinal B-Cell Lymphoma (PMBCL).